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ercutaneous Valve-in-Valve
rocedure for Severe
aravalvular Regurgitation
n Aortic Bioprosthesis
lthough percutaneous aortic valve replacement (PAVR) has
een used to treat severe aortic stenosis for high-risk surgical
atients not suitable for conventional surgery, the feasibility of
sing PAVR for treatment of severe paravalvular regurgitation
n patients with prior aortic valve replacement is unknown. We
ould like to share our experience with an 82-year-old man
eferred for PAVR for treatment of grade 3 paravalvular aortic
egurgitation with a “valve-in-valve” procedure. With a back-
round history of aortic valve replacement (Medtronic Free-
tyle stentless aortic valve, 23 mm; Medtronic Inc., Minneap-
lis, Minnesota) and coronary artery bypass surgery 11 years
revious, New York Heart Association functional class III
eart failure with a biventricular pacemaker in-situ, hyperten-
Figure 1. Multimodal Imaging Evaluation of Percutaneous Aortic “Va
(A) Transesophageal echocardiogram (short-axis view) showing severe pa
valve replacement. (B) Pre-operative computed tomography of Medtronic
tic root and left ventricular (LV) outﬂow tract (*) in the coronal view (a), s
esophageal echocardiogram immediately after implantation of ﬁrst percutane
from the percutaneous aortic valve, distal to the original Medtronic Frees
panel) Long-axis view showing severe aortic regurgitation; (bottom pane
nondeployed aortic cusp (from 12 o’clock to 4 o’clock position). Continueion, diabetes mellitus, and previous transient ischemic attacks,
he patient’s logistic Euroscore was 28%. Pre-operative trans-
sophageal echocardiogram (TEE) showed severe paravalvular
eak (Fig. 1A, Online Video 1), and cardiac computed tomog-
aphy showed a direct paravalvular communication between
he aortic root and left ventricular outflow tract (Fig. 1B).
A 26-mm Edwards-Sapien percutaneous bioprosthetic
alve (Edwards Lifesciences, Inc., Irvine, California) was
mplanted with the transapical approach, under fluoroscopic
nd TEE guidance. The PAVR was implanted, to occlude the
aravalvular leak, in the left ventricular outflow tract, inferior
o the original valve replacement in a valve-in-valve procedure.
owever, TEE showed increased aortic regurgitation severity
ue to nondeployment of a single prosthetic aortic cusp (Fig.
C, Online Videos 2 and 3). A second 26-mm Edwards-
apien percutaneous bioprosthetic valve was implanted in-
etween the 2 previous valves (Fig. 1D, Online Video 4). Final
EE showed a good result with minimal residual paravalvular
eak and mild central aortic regurgitation (Fig. 1E, Online
ideo 5). The patient was followed-up at 1 month, and repeat
ransthoracic echocardiogram and cardiac computed tomogra-
hy showed excellent percutaneous bioprosthetic valve deploy-
n-Valve” Procedure
lvular aortic regurgitation (arrows) in the patient with previous aortic
estyle stentless aortic valve showing free communication between aor-
t-axis aortic level (b), and short-axis LV outﬂow tract level (c). (C) Trans-
aortic valve. B-mode images showed an absent aortic cusp (arrowhead)
stentless valve (arrow), with resultant severe aortic regurgitation. (Top
ort-axis view showing that the severe regurgitation was secondary to a
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523ent (Fig. 1F). This case illustrated the feasibility of using a
alve-in-valve PAVR procedure for treatment of severe paravalvular
ortic regurgitation.
A P P E N D I X
or accompanying videos, please see the online version of this article.
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Figure 1. Continued
(D) Fluoroscopic image demonstrating 2 overlapping percutaneous aortic valve
tract, superior to the ﬁrst percutaneous valve. (E) Post-procedural transesophag
(arrowhead) and mild central aortic regurgitation (arrow). (F) Computed tomog
paravalvular leak at the level of the left ventricular outﬂow tract (c) at 1 month
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ith the second percutaneous valve deployed in the left ventricular outﬂow
chocardiogram (short-axis) view showing minimal residual paravalvular leak
hy of the Edwards-Sapien percutaneous bioprosthetic valves occluding the
ow-up. Please see accompanying Online Videos 1 to 5. Ao  aorta; LA  lefts, w
eal e
rap
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